Skip to main content
SpringerLink
Log in

Idarucizumab und Andexanet Alfa

Antikoagulation bei alten Menschen nach Einführung der Antidota

  • Pharmakotherapie
  • Published:
Geriatrie-Report

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Author information

Authors and Affiliations

  1. Institut für Medizinische Informatik, Biometrie und Epidemiologie (IMIBE)Medizinische Fakultät der Universität Duisburg-Essen, Essen, Germany

    Hans Christoph Diener

  2. Kreisklinikum Siegen Siegen GmbH, Weidenauer Str. 76, 57076, Siegen, Germany

    Martin Grond

Authors
  1. Hans Christoph Diener
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Martin Grond
    View author publications

    You can also search for this author in PubMed Google Scholar

Electronic supplementary material

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Diener, H., Grond, M. Antikoagulation bei alten Menschen nach Einführung der Antidota. Geriatr Rep 16, 28–30 (2021). https://doi.org/10.1007/s42090-020-1220-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s42090-020-1220-5

Search

Navigation